What BMI Do You Need to Qualify for Semaglutide?

Before any reputable telehealth provider will prescribe semaglutide for weight loss, you have to meet medical eligibility criteria. The single most-asked question on those criteria: what BMI do you need?

The short answer: BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related medical condition. That’s the standard the FDA uses for Wegovy® and the standard most legitimate providers (including REMEVi) use for compounded semaglutide.

Here’s exactly what those numbers mean, what conditions count as qualifying comorbidities, and what to expect when you go through the eligibility check.

The Standard BMI Cutoffs for Semaglutide

The clinical eligibility for semaglutide for chronic weight management is based on the criteria the FDA established when it approved Wegovy in 2021:

BMI ≥ 30 (classified as obesity), regardless of other conditions, OR
BMI ≥ 27 (classified as overweight) with at least one weight-related comorbidity

You can calculate BMI as weight in pounds × 703 ÷ (height in inches squared), or use any free online BMI calculator. The CDC’s calculator and most pharmacy websites give the same numbers.

A few quick examples:

5’4”, 180 lbs → BMI of about 30.9 (qualifies on BMI alone)
5’7”, 180 lbs → BMI of about 28.2 (qualifies if you have a comorbidity)
5’10”, 200 lbs → BMI of about 28.7 (qualifies if you have a comorbidity)
5’10”, 215 lbs → BMI of about 30.8 (qualifies on BMI alone)

If you’re between 27 and 30 BMI, the comorbidity question becomes critical.

What Comorbidities Count?

A “weight-related comorbidity” is a medical condition either caused or worsened by excess weight. The most commonly accepted ones for semaglutide eligibility include:

Type 2 diabetes or prediabetes
Hypertension (high blood pressure)
Dyslipidemia (high cholesterol or high triglycerides)
Obstructive sleep apnea
Cardiovascular disease (history of heart attack, stroke, or heart disease)
Non-alcoholic fatty liver disease (NAFLD/NASH)
Polycystic ovary syndrome (PCOS)
Osteoarthritis that affects weight-bearing joints
Asthma when worsened by weight
Gastroesophageal reflux disease (GERD)

If you’ve been diagnosed with any of these — or are taking medication for them — you almost certainly qualify if your BMI is 27 or above.

A few notes:

You don’t need a perfect paper trail. Self-reported diagnoses with current medication or recent labs are usually enough for an initial telehealth evaluation.
Borderline conditions count. Prediabetes, “borderline” hypertension on the verge of medication, and PCOS without a formal diagnosis can all support eligibility — your physician will evaluate.
Mental health conditions related to weight (binge eating disorder, weight-related depression) can also be supportive, though they typically aren’t sufficient on their own.

Why the BMI Standard Exists

The BMI cutoffs aren’t arbitrary. They come from the clinical trials that established semaglutide’s effectiveness and safety profile.

The STEP trials — the studies that supported Wegovy’s FDA approval — enrolled adults with BMI ≥ 30, or BMI ≥ 27 with at least one weight-related condition. Within that population, semaglutide reduced body weight by an average of about 15% over 68 weeks and demonstrated a well-characterized safety profile.

Outside of that population (people with BMI under 27, or under 30 with no comorbidities), the risk-benefit math shifts. The medication still works pharmacologically, but the medical case for prescribing it weakens. Reputable physicians and pharmacies follow the established cutoffs because that’s where the evidence is strongest.

For a fuller breakdown of who qualifies and what the medical reasoning looks like, see our GLP-1 eligibility requirements guide.

What If You’re Just Below the BMI Cutoff?

This is one of the most common situations. You’re 25 BMI and want to lose 15 pounds. Or you’re 26 BMI with no comorbidities. Can you get a prescription anyway?

Probably not from a reputable provider — and that’s a good sign, not a bad one.

Some less-scrupulous platforms will prescribe semaglutide to anyone willing to pay. They’re not doing you a favor. The medication has real side effects and real long-term considerations; using it for cosmetic weight loss outside the established medical criteria is genuinely riskier than the marketing makes it sound.

If you’re under the threshold, the better path is usually:

Lifestyle interventions first — structured nutrition, resistance training, and sleep work can produce 5–10 lb losses for many adults at lower BMIs
A real evaluation for hidden comorbidities — many patients have undiagnosed conditions (sleep apnea, prediabetes, NAFLD) that would actually qualify them
Patience — if your weight is climbing and you’re trending toward 27 or 30, the eligibility door opens

If your BMI is genuinely close to 27 and you’re symptomatic, a real medical evaluation often reveals qualifying conditions that haven’t been formally diagnosed.

How the REMEVi Eligibility Process Works

At REMEVi, the eligibility check is built into the intake — there’s no separate BMI quiz that decides for you, and no rigid checklist that disqualifies legitimate candidates.

Step 1: 5-minute intake form. You provide your height, weight, age, medical history, current medications, and any conditions you’ve been diagnosed with. The form is bilingual (English and Spanish) and designed to take real medical history rather than just box-check.

Step 2: Physician review (within 24 hours). A licensed U.S. physician reviews your full file. If your BMI alone qualifies, you’re approved. If you’re between 27–30 BMI, the physician evaluates which comorbidities apply and whether semaglutide is the right next step.

Step 3: Approval, alternative, or follow-up. Most candidates who meet criteria are approved on the first review. If you’re not a fit for semaglutide specifically, the physician may recommend tirzepatide, additional labs, or a different starting point. You’ll know either way within 24 hours.

Step 4: Prescription and shipping. Once approved, your prescription is sent to a 503B FDA-registered pharmacy, and medication ships within 5–7 business days.

The process is designed to honor the medical standard and respect your time. If you don’t qualify, you don’t get charged for medication you can’t use.

What Information Do You Need Before Starting?

To make the intake go smoothly, gather:

Your current weight and height (this gives BMI)
A list of current medications, especially any for diabetes, blood pressure, cholesterol, or thyroid
Any known diagnoses (the more specific, the better)
Recent labs if available — A1C, lipid panel, basic metabolic panel
Allergies to medications or ingredients
Pregnancy/breastfeeding status — semaglutide is not safe in pregnancy
Family history of medullary thyroid carcinoma or MEN 2 — these are firm contraindications

You don’t need to have all of this in hand. Most patients self-report what they know, and the physician follows up if anything specific is needed.

Common Disqualifiers (Even With High Enough BMI)

Even with a qualifying BMI, semaglutide is not safe for everyone. Standard contraindications include:

Personal or family history of medullary thyroid carcinoma (MTC)
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
History of pancreatitis
Severe gastroparesis (delayed stomach emptying)
Pregnancy, planned pregnancy within 2 months, or breastfeeding
Known allergy to semaglutide or its components
Under age 18 (in most cases)

A licensed physician will screen for all of these during the review.

The Bottom Line

The BMI standard for semaglutide is 30 or higher, or 27 or higher with a weight-related comorbidity. That’s the medical line, and reputable providers stick to it. If you’re in that range, you almost certainly qualify. If you’re between 27 and 30, the comorbidity question is the deciding factor, and a real medical evaluation can identify conditions you may not have known applied.

The intake form is designed to figure this out for you — not to gatekeep, and not to rubber-stamp.

Ready to Start Your GLP-1 Journey?

If you think you might qualify, the easiest way to find out is to complete the 5-minute REMEVi intake. A licensed U.S. physician reviews your file within 24 hours. If you’re approved, compounded semaglutide starts at $199/month, all-inclusive.

If you’re not a fit, you’ll know quickly and you won’t be charged for medication.

Get started with REMEVi →

This article is for informational purposes only and does not constitute medical advice. BMI and comorbidity-based eligibility is determined on a case-by-case basis by a licensed physician.